Braslyn Ltd., 10% Owner at Mirati Therapeutics, Inc. (MRTX), bought 1,166 shares at $19.34 ($23K) on 2016-03-18, disclosed to the SEC on 2016-03-22.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Negative factors outweigh the positive ones.
| Filing → |
| MRTX | SELL | 2020-06-16 | $58.2M | — | Filing → |
| MRTX | SELL | 2019-03-05 | $19.0M | — | Filing → |
| MRTX | BUY | 2017-11-20 | $5.2M | — | Filing → |